Loading…

Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy

Background: The aim of the study is to investigate the factors affecting acute hematologic toxicity (HT) in the adjuvant radiotherapy (RT) of gynecologic cancers by machine learning. Methods: Between January 2015 and September 2018, 121 patients with endometrium and cervical cancer who underwent adj...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of cancer 2022-04, Vol.59 (2), p.178-186
Main Authors: Akcay, Melek, Etiz, Durmus, Celik, Ozer, Ozen, Alaattin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723
cites cdi_FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723
container_end_page 186
container_issue 2
container_start_page 178
container_title Indian journal of cancer
container_volume 59
creator Akcay, Melek
Etiz, Durmus
Celik, Ozer
Ozen, Alaattin
description Background: The aim of the study is to investigate the factors affecting acute hematologic toxicity (HT) in the adjuvant radiotherapy (RT) of gynecologic cancers by machine learning. Methods: Between January 2015 and September 2018, 121 patients with endometrium and cervical cancer who underwent adjuvant RT with volumetric-modulated arc therapy (VMAT) were evaluated. The relationship between patient and treatment characteristics and acute HT was investigated using machine learning techniques, namely Logistic Regression, XGBoost, Artificial Neural Network, Random Forest, Naive Bayes, Support Vector Machine (SVM), and Gaussian Naive Bayes (GaussianNB) algorithms. Results: No HT was observed in 11 cases (9.1%) and at least one grade of HT was observed in 110 cases. There were 55 (45.5%) cases with ≤grade 2 HT (mild HT) and 66 (54.5%) cases with grade ≥3 HT (severe HT). None of the patients developed grade 5 HT. Of 24 variables that could affect acute HT, nine were determined as important variables. According to the results, the best machine learning technique for acute HT estimation was SVM (accuracy 70%, area under curve (AUC): 0.65, sensitivity 71.4%, specificity 66.6%). Parameters affecting hematologic toxicity were evaluated also by classical statistical methods and there was a statistically significant relationship between age, RT, and bone marrow (BM) maximum dose. Conclusion: It is important to predict the patients who will develop acute HT in order to minimize the side effects of treatment. If these cases can be identified in advance, toxicity rates can be reduced by taking necessary precautions. These cases can be predicted with machine learning algorithms.
doi_str_mv 10.4103/ijc.IJC_666_19
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2704778163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714596352</galeid><sourcerecordid>A714596352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723</originalsourceid><addsrcrecordid>eNp1ksGL1DAUxosoOK5ePQcEbx2Tpk2bm8uw6i4LXhS8hTR9bTObJjVJZ-x_b4ZRdoWRHEKS3_eF996XZW8J3pYE0w96r7a3dzvBGBOEP8s2hPMmL-u6fJ5tMCY8rzD_8TJ7FcIe44IWZbPJDjcHaRYZtbPI9UiqJQIaYZLRGTdoJQ2K7pdWOq6oXdEk1agtIAPSW20HpC0aVgvqTCMlrQIf0BJOj7ML0c3gk_0BkJeddnFMx3l9nb3opQnw5s9-lX3_dPNt9yW___r5dnd9n6uyoDqXVOK2aVnV9aroGSE143UBqmo4J2XHWS8LqFRb9B0rFa2AdlUrKw6NbFhdF_Qqe3f2nb37uUCIYu8Wb9OXoqhx6k1DGH2kBmlAaNu76KWadFDiuiZlxRmtTl75BWoAmyoyzkKv0_U__PYCn1YHk1YXBe-fCEaQJo7BmeU0nHDRWXkXgodezF5P0q-CYHHKgkhZEI9ZSIKPZ8HRmZjm82CWI3gxQfdg3fE_KkHqRvyNB_0NgIq--A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2704778163</pqid></control><display><type>article</type><title>Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy</title><source>Publicly Available Content Database</source><creator>Akcay, Melek ; Etiz, Durmus ; Celik, Ozer ; Ozen, Alaattin</creator><creatorcontrib>Akcay, Melek ; Etiz, Durmus ; Celik, Ozer ; Ozen, Alaattin</creatorcontrib><description>Background: The aim of the study is to investigate the factors affecting acute hematologic toxicity (HT) in the adjuvant radiotherapy (RT) of gynecologic cancers by machine learning. Methods: Between January 2015 and September 2018, 121 patients with endometrium and cervical cancer who underwent adjuvant RT with volumetric-modulated arc therapy (VMAT) were evaluated. The relationship between patient and treatment characteristics and acute HT was investigated using machine learning techniques, namely Logistic Regression, XGBoost, Artificial Neural Network, Random Forest, Naive Bayes, Support Vector Machine (SVM), and Gaussian Naive Bayes (GaussianNB) algorithms. Results: No HT was observed in 11 cases (9.1%) and at least one grade of HT was observed in 110 cases. There were 55 (45.5%) cases with ≤grade 2 HT (mild HT) and 66 (54.5%) cases with grade ≥3 HT (severe HT). None of the patients developed grade 5 HT. Of 24 variables that could affect acute HT, nine were determined as important variables. According to the results, the best machine learning technique for acute HT estimation was SVM (accuracy 70%, area under curve (AUC): 0.65, sensitivity 71.4%, specificity 66.6%). Parameters affecting hematologic toxicity were evaluated also by classical statistical methods and there was a statistically significant relationship between age, RT, and bone marrow (BM) maximum dose. Conclusion: It is important to predict the patients who will develop acute HT in order to minimize the side effects of treatment. If these cases can be identified in advance, toxicity rates can be reduced by taking necessary precautions. These cases can be predicted with machine learning algorithms.</description><identifier>ISSN: 0019-509X</identifier><identifier>EISSN: 1998-4774</identifier><identifier>DOI: 10.4103/ijc.IJC_666_19</identifier><language>eng</language><publisher>Mumbai: Wolters Kluwer India Pvt. Ltd</publisher><subject>Adjuvant treatment ; Algorithms ; Cancer ; Care and treatment ; Cervical cancer ; Evidence-based medicine ; Machine learning ; Neural networks ; Radiation therapy ; Radiotherapy ; Support vector machines</subject><ispartof>Indian journal of cancer, 2022-04, Vol.59 (2), p.178-186</ispartof><rights>COPYRIGHT 2022 Medknow Publications and Media Pvt. Ltd.</rights><rights>2022. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723</citedby><cites>FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2704778163?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25751,27922,27923,37010,44588</link.rule.ids></links><search><creatorcontrib>Akcay, Melek</creatorcontrib><creatorcontrib>Etiz, Durmus</creatorcontrib><creatorcontrib>Celik, Ozer</creatorcontrib><creatorcontrib>Ozen, Alaattin</creatorcontrib><title>Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy</title><title>Indian journal of cancer</title><description>Background: The aim of the study is to investigate the factors affecting acute hematologic toxicity (HT) in the adjuvant radiotherapy (RT) of gynecologic cancers by machine learning. Methods: Between January 2015 and September 2018, 121 patients with endometrium and cervical cancer who underwent adjuvant RT with volumetric-modulated arc therapy (VMAT) were evaluated. The relationship between patient and treatment characteristics and acute HT was investigated using machine learning techniques, namely Logistic Regression, XGBoost, Artificial Neural Network, Random Forest, Naive Bayes, Support Vector Machine (SVM), and Gaussian Naive Bayes (GaussianNB) algorithms. Results: No HT was observed in 11 cases (9.1%) and at least one grade of HT was observed in 110 cases. There were 55 (45.5%) cases with ≤grade 2 HT (mild HT) and 66 (54.5%) cases with grade ≥3 HT (severe HT). None of the patients developed grade 5 HT. Of 24 variables that could affect acute HT, nine were determined as important variables. According to the results, the best machine learning technique for acute HT estimation was SVM (accuracy 70%, area under curve (AUC): 0.65, sensitivity 71.4%, specificity 66.6%). Parameters affecting hematologic toxicity were evaluated also by classical statistical methods and there was a statistically significant relationship between age, RT, and bone marrow (BM) maximum dose. Conclusion: It is important to predict the patients who will develop acute HT in order to minimize the side effects of treatment. If these cases can be identified in advance, toxicity rates can be reduced by taking necessary precautions. These cases can be predicted with machine learning algorithms.</description><subject>Adjuvant treatment</subject><subject>Algorithms</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Cervical cancer</subject><subject>Evidence-based medicine</subject><subject>Machine learning</subject><subject>Neural networks</subject><subject>Radiation therapy</subject><subject>Radiotherapy</subject><subject>Support vector machines</subject><issn>0019-509X</issn><issn>1998-4774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1ksGL1DAUxosoOK5ePQcEbx2Tpk2bm8uw6i4LXhS8hTR9bTObJjVJZ-x_b4ZRdoWRHEKS3_eF996XZW8J3pYE0w96r7a3dzvBGBOEP8s2hPMmL-u6fJ5tMCY8rzD_8TJ7FcIe44IWZbPJDjcHaRYZtbPI9UiqJQIaYZLRGTdoJQ2K7pdWOq6oXdEk1agtIAPSW20HpC0aVgvqTCMlrQIf0BJOj7ML0c3gk_0BkJeddnFMx3l9nb3opQnw5s9-lX3_dPNt9yW___r5dnd9n6uyoDqXVOK2aVnV9aroGSE143UBqmo4J2XHWS8LqFRb9B0rFa2AdlUrKw6NbFhdF_Qqe3f2nb37uUCIYu8Wb9OXoqhx6k1DGH2kBmlAaNu76KWadFDiuiZlxRmtTl75BWoAmyoyzkKv0_U__PYCn1YHk1YXBe-fCEaQJo7BmeU0nHDRWXkXgodezF5P0q-CYHHKgkhZEI9ZSIKPZ8HRmZjm82CWI3gxQfdg3fE_KkHqRvyNB_0NgIq--A</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Akcay, Melek</creator><creator>Etiz, Durmus</creator><creator>Celik, Ozer</creator><creator>Ozen, Alaattin</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20220401</creationdate><title>Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy</title><author>Akcay, Melek ; Etiz, Durmus ; Celik, Ozer ; Ozen, Alaattin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adjuvant treatment</topic><topic>Algorithms</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Cervical cancer</topic><topic>Evidence-based medicine</topic><topic>Machine learning</topic><topic>Neural networks</topic><topic>Radiation therapy</topic><topic>Radiotherapy</topic><topic>Support vector machines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akcay, Melek</creatorcontrib><creatorcontrib>Etiz, Durmus</creatorcontrib><creatorcontrib>Celik, Ozer</creatorcontrib><creatorcontrib>Ozen, Alaattin</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Indian journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akcay, Melek</au><au>Etiz, Durmus</au><au>Celik, Ozer</au><au>Ozen, Alaattin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy</atitle><jtitle>Indian journal of cancer</jtitle><date>2022-04-01</date><risdate>2022</risdate><volume>59</volume><issue>2</issue><spage>178</spage><epage>186</epage><pages>178-186</pages><issn>0019-509X</issn><eissn>1998-4774</eissn><abstract>Background: The aim of the study is to investigate the factors affecting acute hematologic toxicity (HT) in the adjuvant radiotherapy (RT) of gynecologic cancers by machine learning. Methods: Between January 2015 and September 2018, 121 patients with endometrium and cervical cancer who underwent adjuvant RT with volumetric-modulated arc therapy (VMAT) were evaluated. The relationship between patient and treatment characteristics and acute HT was investigated using machine learning techniques, namely Logistic Regression, XGBoost, Artificial Neural Network, Random Forest, Naive Bayes, Support Vector Machine (SVM), and Gaussian Naive Bayes (GaussianNB) algorithms. Results: No HT was observed in 11 cases (9.1%) and at least one grade of HT was observed in 110 cases. There were 55 (45.5%) cases with ≤grade 2 HT (mild HT) and 66 (54.5%) cases with grade ≥3 HT (severe HT). None of the patients developed grade 5 HT. Of 24 variables that could affect acute HT, nine were determined as important variables. According to the results, the best machine learning technique for acute HT estimation was SVM (accuracy 70%, area under curve (AUC): 0.65, sensitivity 71.4%, specificity 66.6%). Parameters affecting hematologic toxicity were evaluated also by classical statistical methods and there was a statistically significant relationship between age, RT, and bone marrow (BM) maximum dose. Conclusion: It is important to predict the patients who will develop acute HT in order to minimize the side effects of treatment. If these cases can be identified in advance, toxicity rates can be reduced by taking necessary precautions. These cases can be predicted with machine learning algorithms.</abstract><cop>Mumbai</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><doi>10.4103/ijc.IJC_666_19</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0019-509X
ispartof Indian journal of cancer, 2022-04, Vol.59 (2), p.178-186
issn 0019-509X
1998-4774
language eng
recordid cdi_proquest_journals_2704778163
source Publicly Available Content Database
subjects Adjuvant treatment
Algorithms
Cancer
Care and treatment
Cervical cancer
Evidence-based medicine
Machine learning
Neural networks
Radiation therapy
Radiotherapy
Support vector machines
title Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20acute%20hematological%20toxicity%20by%20machine%20learning%20in%20gynecologic%20cancers%20using%20postoperative%20radiotherapy&rft.jtitle=Indian%20journal%20of%20cancer&rft.au=Akcay,%20Melek&rft.date=2022-04-01&rft.volume=59&rft.issue=2&rft.spage=178&rft.epage=186&rft.pages=178-186&rft.issn=0019-509X&rft.eissn=1998-4774&rft_id=info:doi/10.4103/ijc.IJC_666_19&rft_dat=%3Cgale_proqu%3EA714596352%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423i-a3a0b8b65dfc2f61176972ec589914d96fa2e5cb2fd64c35e3d5ba59e8a867723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2704778163&rft_id=info:pmid/&rft_galeid=A714596352&rfr_iscdi=true